Cinclus Pharma Holding AB (publ) (STO:CINPHA)

Cinclus Pharma Holding AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	588.96	566.72	87.97	173.55	138.2	208.5
Cash & Short-Term Investments	588.96	566.72	87.97	173.55	138.2	208.5
Cash Growth	-13.98%	544.20%	-49.31%	25.57%	-33.72%	1449.96%
Accounts Receivable	-	4.58	-	-	-	-
Other Receivables	2.03	2.93	3.98	10.23	1.38	0.17
Receivables	2.03	7.51	3.98	10.23	1.38	0.17
Prepaid Expenses	30.51	1.23	2.14	1.11	0.39	0.11
Other Current Assets	-	25.02	-	-	5.38	3.6
Total Current Assets	621.5	600.47	94.09	184.88	145.36	212.39
Property, Plant & Equipment	0.39	0.54	0.32	0.89	1.82	0.02
Other Long-Term Assets	0.3	0	0	0	0	0.07
Total Assets	622.19	601.01	94.41	185.77	147.18	212.47
Accounts Payable	10.49	18.93	16.45	16.95	9.19	5.42
Accrued Expenses	30.05	16.9	6.83	20.47	7.51	0.64
Short-Term Debt	-	-	131.01	-	-	-
Current Portion of Leases	0.11	0.11	0.02	0.54	0.85	-
Current Income Taxes Payable	6.99	7.45	7.22	5.4	-	-
Other Current Liabilities	2.73	2.11	2.9	2.74	1.92	0.43
Total Current Liabilities	80.17	45.49	164.42	46.1	19.47	6.49
Long-Term Leases	0.13	0.19	-	-	0.61	-
Other Long-Term Liabilities	0	-	6.79	12.8	-	-
Total Liabilities	150.75	45.68	171.21	58.9	20.08	6.49
Common Stock	0.92	0.92	0.51	0.51	0.26	0.26
Additional Paid-In Capital	1,298	1,298	503.52	503.69	276.74	271.72
Retained Earnings	-852.53	-772	-606.84	-394.16	-145.08	-68.82
Comprehensive Income & Other	25.3	28.67	26	16.84	-4.82	2.82
Shareholders' Equity	471.43	555.33	-76.8	126.87	127.1	205.99
Total Liabilities & Equity	622.19	601.01	94.41	185.77	147.18	212.47
Total Debt	0.25	0.3	131.03	0.54	1.46	-
Net Cash (Debt)	588.71	566.42	-43.06	173	136.75	208.5
Net Cash Growth	-13.95%	-	-	26.51%	-34.41%	1449.96%
Net Cash Per Share	14.07	15.29	-1.64	7.51	6.48	841.82
Filing Date Shares Outstanding	46.54	46.54	26.23	0.33	0.26	0.25
Total Common Shares Outstanding	46.54	46.54	26.23	0.33	0.26	0.25
Working Capital	541.33	554.97	-70.33	138.78	125.89	205.9
Book Value Per Share	10.13	11.93	-2.93	387.00	481.30	831.67
Tangible Book Value	471.43	555.33	-76.8	126.87	127.1	205.99
Tangible Book Value Per Share	10.13	11.93	-2.93	387.00	481.30	831.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.